Cellular functions of the plasma membrane estrogen receptor

Trends in Endocrinology and Metabolism

Volumn 10, Issue 9, 1999, Pages 374-377

  Levin, Ellis R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; MEMBRANE RECEPTOR;

BONE METABOLISM; CELL FUNCTION; CELL MEMBRANE; CELL PROLIFERATION; HEART PROTECTION; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0033230631     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00192-7     Document Type: Review

References (47)

1. Pietras, R. and Szego, C.M. (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265, 69-72
2. Pietras, R.J. and Szego, C.M. (1980) Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem. J. 191, 743-760
3. Blackmore, P.F., Neulen, J., Lattanzio, F. and Beebe, S.J. (1991) Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J. Biol. Chem. 266, 18655-18659
4. Gametchu, B. (1987) Glucocorticoid receptor-like antigen in lymphoma cell membranes: Correlation to cell lysis. Science 236, 456-461
5. Nemere, I., Dormanen, M.C., Hammond, M.W., Okamura, W.H. and Norman, A.W. (1994) Identification of a specific binding protein for 1α,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269, 23750-23756
6. Wehling, M. (1995) Nongenomic aldosterone effects: The cell membrane as a specific target of mineralocorticoid action. Steroids 60, 153-156
7. Tesarik, J. and Mendoza, C. (1995) Nongenomic effects of 17 beta-estradiol on maturing human oocytes: Relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80, 1438-1443
8. Aronica, S.M., Kraus, W.L. and Katznellenbogen, B.S. (1994) Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U. S. A. 91, 8517-8521
9. Le Mellay, V., Grosse, B. and Lieberherr, M. (1997) Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272, 11902-11907
10. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C. and Brown, M. (1994) Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science 264, 1455-1458
11. Migliaccio, A. et al. (1996) Tyrosine kinase/p21ras/ MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15, 1292-1300
12. 44 mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U. S. A. 90, 8319-8323
13. Watters, J.J., Campbell, J.S., Cunningham, M.J., Krebs, E.G. and Dorsa, D.M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138, 4030-4033
14. Janknecht, R., Ernst, W.H., Lingoud, V. and Nordheim, A. (1993) Activation of TCF elk-1 by MAP kinases. EMBO J. 12, 5097-5104
15. Morey, A.K., Razandi, M., Pedram, A., Hu, R-M., Prins, B. and Levin, E.R. (1998) Estrogen and progesterone inhibit the stimulated production of endothelin-1: Differential positive and negative regulatory mechanisms. Biochem. J. 330, 1097-1105
16. Yallampalli, C., Byam-Smith, M., Nelson, S.O. and Garfield, R.E. (1994) Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 134, 1971-1974
17. Hayashi, T. et al. (1995) Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem. Biophys. Res. Commun. 214, 847-855
18. Rubanyi, G.M. et al. (1997) Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J. Clin. Invest. 99, 2429-2437
19. Chen, Z., Yuhanna, I.S., Galcheva-Gargova, Z., Karas, R.H., Mendelsohn, M.E. and Shaul, P.W. (1999) Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406
20. Prevot, V. et al. (1999) Estradiol coupling to nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology 140, 652-659
21. Pappas, T.C., Gametchu, B., Yannariello-Brown, J., Collins, T.J. and Watson, C.S. (1994) Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2, 813-822
22. Razandi, M., Pedram, A., Greene, G.L. and Levin, E.R. (1999) Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERα and ERβ expressed in CHO cells. Mol. Endocrinol. 13, 307-319
23. Pappas, T.C., Gametchu, B. and Watson, C.S. (1995) Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9, 404-410
24. Morey, A.K. et al. (1997) Estrogen and progesterone inhibit human vascular smooth muscle proliferation. Endocrinology 138, 3330-3339
25. Stampfer, M.J., Willett, W.C., Colditz, G.A., Rosner, B., Speizer, F.E. and Hennekens, C.H. (1991) Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow up from the nurses health study. New Engl. J. Med. 325, 756-762
26. White, R.E., Darkow, D.J. and Lang, J.L. (1995) Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ. Res. 77, 936-942
27. 2⊃⊂ currents in aortic smooth muscle cells. Eur. J. Pharmacol. 294, 625-635
28. Farhat, M.Y., Abi-Younes, S., Dingaan, B., Vargas, R. and Ramwell, P.W. (1996) Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J. Pharmacol. Exp. Ther. 276, 652-657
29. Lieberherr, M., Grosse, B., Kachkache, M. and Balsan, S. (1993) Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors. J. Bone Miner. Res. 8, 1365-1376
30. Fiorelli, G. et al. (1996) Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells. J. Steroid Biochem. Mol. Biol. 59, 233-240
31. Sylvia, V.L., Hughes, T., Dean, D.D., Boyan, B.D. and Schwartz, Z. (1998) 17beta-estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms. J. Cell. Physiol. 176, 435-444
32. Schwartz, Z. et al. (1996) Effect of 17 beta-estradiol on chondrocyte membrane fluidity and phospholipid metabolism is membrane-specific, sex-specific, and cell maturation-dependent. Biochim. Biophys. Acta 1282, 1-10
33. Kaji, H., Sugimoto, T., Kanatani, M., Nasu, M. and Chihara, K. (1996) Estrogen blocks parathyroid hormone (pth)-stimulated osteoclast-like cell formation by selectively affecting pth-responsive cyclic adenosine mono- Phosphate pathway. Endocrinology 137, 2217-2224
34. Shi, J., Zhang, Y.Q. and Simpkins, J.W. (1977) Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp. Brain Res. 117, 200-206
35. Behl, C., Widmann, M., Trapp, T. and Holsboer, F. (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482
36. Simpkins, J.W. et al. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87, 724-730
37. Panickar, K.S., Purushotham, K., King, M.A., Rajakumar, G. and Simpkins, J.W. (1998) Hypoglycemia-induced seizures reduce cyclic AMP response element binding protein levels in the rat hippocampus. Neuroscience 83, 1155-1160
38. Gridley, K.E., Green, P.S. and Simpkins, J.W. (1998) A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54, 874-880
39. Simpkins, J.W. et al. (1997) Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am. J. Med. 103, 19S-25S
40. Schmidt, R. et al. (1996) Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44, 1307-1313
41. Ross, J.L., Roeltgen, D., Feuillan, P., Kushner, H. and Cutler, G.B., Jr (1998) Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 83, 3198-3204
42. Singer, C.A., Figueroa-Masot, X.A., Batchelor, R.H. and Dorsa, D.M. (1999) The mitogen activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463
43. Nelson, K.G., Takahashi, T., Bossert, N.L., Walmer, D.K. and McLachlan, J.A. (1991) Epidermal growth factor replaces estrogen in the stimulation of female genitaltract growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 88, 21-25
44. Daub, H., Weiss, F.U., Wallasch, C. and Ullrich, A. (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557-560
45. Bunone, G., Briand, P.A., Miksicek, R.J. and Picard, D. (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183
46. Pietras, R.J. et al. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10, 2435-2446
47. Nakhla, A.M., Romas, N.A. and Rosner, W. (1997) Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. J. Biol. Chem. 272, 6838-6841